🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/03/2002 | 55,92 | 57,45 | 55,40 | 55,77 | +0,27% | 3,68% | 84.345 |
| 04/03/2002 | 54,20 | 56,52 | 54,09 | 55,62 | +2,48% | 4,49% | 95.432 |
| 01/03/2002 | 54,46 | 54,61 | 53,34 | 54,27 | +0,97% | 2,34% | 85.039 |
| 28/02/2002 | 54,72 | 55,13 | 53,23 | 53,75 | -2,64% | 3,49% | 61.395 |
| 27/02/2002 | 53,82 | 56,14 | 53,82 | 55,21 | +3,87% | 4,31% | 115.042 |
| 26/02/2002 | 52,03 | 53,60 | 51,84 | 53,15 | +2,31% | 3,38% | 68.021 |
| 25/02/2002 | 52,66 | 53,67 | 50,94 | 51,95 | -1,35% | 5,19% | 132.248 |
| 22/02/2002 | 50,16 | 52,66 | 49,78 | 52,66 | +1,96% | 5,75% | 97.115 |
| 21/02/2002 | 53,23 | 54,65 | 51,65 | 51,65 | -3,43% | 5,63% | 49.880 |
| 20/02/2002 | 53,90 | 54,46 | 51,50 | 53,49 | +0,14% | 5,49% | 65.162 |
| 19/02/2002 | 55,77 | 55,77 | 53,34 | 53,41 | -3,58% | 4,36% | 50.174 |
| 15/02/2002 | 54,42 | 56,26 | 53,34 | 55,40 | +1,72% | 5,36% | 47.235 |
| 14/02/2002 | 56,26 | 56,26 | 54,27 | 54,46 | -2,87% | 3,53% | 37.056 |
| 13/02/2002 | 54,35 | 56,26 | 54,35 | 56,07 | +2,25% | 3,51% | 31.686 |
| 12/02/2002 | 54,20 | 55,77 | 53,45 | 54,83 | +2,09% | 4,28% | 82.127 |
| 11/02/2002 | 52,96 | 54,46 | 52,81 | 53,71 | +0,84% | 3,11% | 45.899 |
| 08/02/2002 | 50,27 | 53,52 | 50,27 | 53,26 | +5,96% | 6,48% | 73.364 |
| 07/02/2002 | 51,28 | 51,47 | 47,35 | 50,27 | -2,33% | 8,03% | 105.290 |
| 06/02/2002 | 53,23 | 53,34 | 50,72 | 51,47 | -3,44% | 4,92% | 71.227 |
| 05/02/2002 | 51,28 | 54,27 | 51,28 | 53,30 | +0,99% | 5,84% | 149.640 |
| 04/02/2002 | 56,37 | 56,37 | 52,78 | 52,78 | -10,76% | 6,37% | 176.570 |
| 01/02/2002 | 56,00 | 59,14 | 55,96 | 59,14 | +4,77% | 5,68% | 59.124 |
| 31/01/2002 | 56,33 | 57,64 | 55,36 | 56,44 | +1,69% | 4,05% | 57.975 |
| 30/01/2002 | 59,40 | 59,44 | 52,96 | 55,51 | -6,67% | 10,90% | 291.986 |
| 29/01/2002 | 59,70 | 60,04 | 58,88 | 59,48 | -0,38% | 1,94% | 106.225 |
| 28/01/2002 | 62,62 | 62,62 | 59,70 | 59,70 | -3,04% | 4,66% | 123.137 |
| 25/01/2002 | 60,26 | 62,47 | 60,07 | 61,57 | +0,61% | 3,98% | 27.198 |
| 24/01/2002 | 63,07 | 63,07 | 61,01 | 61,20 | -0,30% | 3,26% | 25.087 |
| 23/01/2002 | 59,51 | 62,51 | 58,20 | 61,38 | +3,14% | 7,23% | 78.120 |
| 22/01/2002 | 59,55 | 60,56 | 58,43 | 59,51 | +0,32% | 3,58% | 50.548 |